Germany Melanoma Market: Segmented by Type, Diagnosis & Treatment - Growth, Trends, and Forecasts (2019 2028)
- Published Date: 2022-12-28
- Report ID: 139855
- Pages: 200
-
Format:
Report Overview
Germanys Melanoma market size stood at around USD XX.X billion in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of around 7.4% during the forecast period.
Germany is one of the largest markets for melanoma cancer diagnostics in Europe. Rapid melanoma treatment market growth is anticipated over the forecast period due to the expanding melanoma treatment population and the continued uptake of recently approved drugs.
The melanoma pipeline is currently strong, with several promising molecules in development including, Polynoma's seviprotimut-L, Amgen's talimogene laherparepvec (T-VEC) and Roche and Genentech's cobimetinib in combination with Zelboraf, which are in development for Cutaneous Melanoma, as well as AstraZeneca's selumetinib which is in development for Ocular Melanoma.
Market Drivers
Increase in melanoma cases, presence of effective immunotherapies acts as primary market drivers for Germany melanoma market. Furthermore, Government initiatives aided for that growth, and Technological advancements & increasing R&D on cancer diagnosis and management fueled the market.
1. Germany Melanoma Market Overview........................
A. Market Size
2. Market Drivers..
A. Increase in melanoma cases
B. Presence of effective immunotherapies
C. Increasing R&D
D. Government Initiatives
3. Major Melanoma Cancer Stages.
A. Stage 0
B. Stage 1
C. Stage 2
D. Stage 3
E. Stage 4
4. Melanoma Market Segmentation........................
A. By type
a. Cutaneous Melanoma (CM)
b. Ocular Melanoma (OM)
c. Mucosal Melanoma (MM)
d. Melanoma of the internal organs
B. By Diagnosis
a. Dermatoscopy
b. Sentinel lymph node biopsy
c. X-rays
d. Blood tests
e. CT scan & Ultrasound
C. By Treatment Type
a. Excision and Mohs surgery
b. Chemotherapy
c. Biological therapy
d. Targeted therapy
e. Radiotherapy
f. Immune therapy
g. Lymphadenectomy
5. Melanoma Major Products Market Share
A. Market Analysis, Insights and Forecast By Revenue
6. Competitive Landscape...
A. Major Players
B. Products in Pipeline
7. Key Company Profiles..
A. AstraZeneca Company overview, Product & Services, Strategies & Financials
B. Eli Lilly Company overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth
A. New Trends and Developments
10. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
